Sep 22, 2020
Sep 22, 2020

byprotokinetixp

dry-eye | Ocular inflammation

Dry Eye Disease: Investor Presentation

Dry eye disease (DED) is a multifactorial disease of the ocular surface which results in a spectrum of symptoms and/or signs that affect 5 30% of the population. Download our dry eye disease investors deck to learn how Protokinetix is creating biotechnology that can help change the future of how we treat dry eye disease.

Subscribe for updates

Get alerts about company news and key findings directly in your inbox.